| 亞盛醫藥集團, 06855.HK - 公司概覽 |
| 集團主席 |
楊大俊 |
| 發行股本(股) |
290,000,000 |
| 面值幣種 |
美元 |
| 股票面值 |
1.0E-4 |
| 行業分類 |
生物技術 |
| 公司業務 |
集團為一間放眼全球的臨床階段生物科技公司，從事開發治療癌症、乙型肝炎病毒(HBV)及衰老相關疾病的新型療法。 |
資料來源於上市公司財務報表
|
We've noticed you're using an ad blocker
We spend millions of dollars each year so you can access, for FREE, the highest quality real-time quotes and charts. This is made possible only thanks to the advertising on our site.
To continue using 88iv.com, please allow this domain on your ad blocker.
We are thanksful for your decisive action.
This notice will be shown again every hour.
Close This Window